한글목차

개요

말초혈관 진단 시스템 시장은 2023-2028년 1억 7,807만 달러로 예측되며, 예측 기간 동안 7.16%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 말초혈관 진단 시스템 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 당뇨병에 대한 인식 증가와 함께 당뇨병 유병률 증가, 비침습적이고 방사선을 사용하지 않는 기술에 대한 수요 증가, 휴대용 및 휴대용에 대한 수요 증가 등이 시장을 주도하고 있습니다.

이 보고서는 말초혈관 진단 시스템의 기술 발전이 향후 몇 년 동안 말초혈관 진단 시스템 시장 성장을 주도하는 주요 요인 중 하나라고 지적했습니다. 또한 원격 의료 및 원격 환자 모니터링의 증가, 말초혈관 진단 시스템에 AI 및 ML의 통합은 시장 수요를 크게 증가시킬 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계

제3장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 말초혈관 진단 시스템 세계 시장 2018-2022
• 최종사용자 부문 분석 2018-2022
• 제품 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원과 진료소 : 시장 규모와 예측 2023-2028
• 외래 수술 센터 : 시장 규모와 예측 2023-2028
• 의사 진찰실 : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 시스템 : 시장 규모와 예측 2023-2028
• 액세서리 : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 프랑스 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 상황

• 개요
• 벤더 상황
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Abbott Laboratories
• ACI Medical LLC
• Biomedix
• Boston Scientific Corp.
• Cook Group Inc.
• Cordis Corp.
• D. E. Hokanson Inc.
• Fukuda Denshi Co. Ltd.
• Huntleigh Healthcare Ltd.
• Koven Technology Inc.
• OMRON Corp.
• Perimed AB
• Teleflex Inc.
• Unetixs Vascular Inc.
• Viasonix Ltd

제13장 부록

영문목차

Abstract

The peripheral vascular diagnostic systems market is forecasted to grow by USD 178.07 mn during 2023-2028, accelerating at a CAGR of 7.16% during the forecast period. The report on the peripheral vascular diagnostic systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diabetes coupled with increasing diabetes awareness, rising demand for non-invasive and radiation-free techniques, and growing demand for portable and handheld peripheral vascular diagnostic systems.

Technavio's peripheral vascular diagnostic systems market is segmented as below:

By End-user

• Hospitals and clinics
• Ambulatory surgical centers
• Physician office

By Product

• Systems
• Accessories

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in peripheral vascular diagnostic systems as one of the prime reasons driving the peripheral vascular diagnostic systems market growth during the next few years. Also, rise in telemedicine and remote patient monitoring and integration of AI and ML in peripheral vascular diagnostic systems will lead to sizable demand in the market.

The report on the peripheral vascular diagnostic systems market covers the following areas:

• Peripheral vascular diagnostic systems market sizing
• Peripheral vascular diagnostic systems market forecast
• Peripheral vascular diagnostic systems market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral vascular diagnostic systems market vendors that include Abbott Laboratories, ACI Medical LLC, Boston Scientific Corp., Cook Group Inc., Cordis Corp., D. E. Hokanson Inc., Huntleigh Healthcare Ltd., Koven Technology Inc., Medtronic Plc, OMRON Corp., Perimed AB, Teleflex Inc., Unetixs Vascular Inc., Viasonix Ltd, Fukuda Denshi Co. Ltd., and Biomedix. Also, the peripheral vascular diagnostic systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global peripheral vascular diagnostic systems market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global peripheral vascular diagnostic systems market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospitals and clinics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• 6.4 Ambulatory surgical centers - Market size and forecast 2023-2028
• Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
• 6.5 Physician office - Market size and forecast 2023-2028
• Exhibit 42: Chart on Physician office - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Physician office - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Physician office - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Physician office - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Systems - Market size and forecast 2023-2028
• Exhibit 52: Chart on Systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Systems - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Systems - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Systems - Year-over-year growth 2023-2028 (%)
• 7.4 Accessories - Market size and forecast 2023-2028
• Exhibit 56: Chart on Accessories - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Accessories - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Accessories - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Accessories - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 111: Abbott Laboratories - Overview
• Exhibit 112: Abbott Laboratories - Business segments
• Exhibit 113: Abbott Laboratories - Key news
• Exhibit 114: Abbott Laboratories - Key offerings
• Exhibit 115: Abbott Laboratories - Segment focus
• 12.4 ACI Medical LLC
• Exhibit 116: ACI Medical LLC - Overview
• Exhibit 117: ACI Medical LLC - Product / Service
• Exhibit 118: ACI Medical LLC - Key offerings
• 12.5 Biomedix
• Exhibit 119: Biomedix - Overview
• Exhibit 120: Biomedix - Product / Service
• Exhibit 121: Biomedix - Key offerings
• 12.6 Boston Scientific Corp.
• Exhibit 122: Boston Scientific Corp. - Overview
• Exhibit 123: Boston Scientific Corp. - Business segments
• Exhibit 124: Boston Scientific Corp. - Key news
• Exhibit 125: Boston Scientific Corp. - Key offerings
• Exhibit 126: Boston Scientific Corp. - Segment focus
• 12.7 Cook Group Inc.
• Exhibit 127: Cook Group Inc. - Overview
• Exhibit 128: Cook Group Inc. - Product / Service
• Exhibit 129: Cook Group Inc. - Key offerings
• 12.8 Cordis Corp.
• Exhibit 130: Cordis Corp. - Overview
• Exhibit 131: Cordis Corp. - Product / Service
• Exhibit 132: Cordis Corp. - Key offerings
• 12.9 D. E. Hokanson Inc.
• Exhibit 133: D. E. Hokanson Inc. - Overview
• Exhibit 134: D. E. Hokanson Inc. - Product / Service
• Exhibit 135: D. E. Hokanson Inc. - Key offerings
• 12.10 Fukuda Denshi Co. Ltd.
• Exhibit 136: Fukuda Denshi Co. Ltd. - Overview
• Exhibit 137: Fukuda Denshi Co. Ltd. - Business segments
• Exhibit 138: Fukuda Denshi Co. Ltd. - Key offerings
• Exhibit 139: Fukuda Denshi Co. Ltd. - Segment focus
• 12.11 Huntleigh Healthcare Ltd.
• Exhibit 140: Huntleigh Healthcare Ltd. - Overview
• Exhibit 141: Huntleigh Healthcare Ltd. - Product / Service
• Exhibit 142: Huntleigh Healthcare Ltd. - Key offerings
• 12.12 Koven Technology Inc.
• Exhibit 143: Koven Technology Inc. - Overview
• Exhibit 144: Koven Technology Inc. - Product / Service
• Exhibit 145: Koven Technology Inc. - Key offerings
• 12.13 OMRON Corp.
• Exhibit 146: OMRON Corp. - Overview
• Exhibit 147: OMRON Corp. - Business segments
• Exhibit 148: OMRON Corp. - Key news
• Exhibit 149: OMRON Corp. - Key offerings
• Exhibit 150: OMRON Corp. - Segment focus
• 12.14 Perimed AB
• Exhibit 151: Perimed AB - Overview
• Exhibit 152: Perimed AB - Product / Service
• Exhibit 153: Perimed AB - Key offerings
• 12.15 Teleflex Inc.
• Exhibit 154: Teleflex Inc. - Overview
• Exhibit 155: Teleflex Inc. - Business segments
• Exhibit 156: Teleflex Inc. - Key news
• Exhibit 157: Teleflex Inc. - Key offerings
• Exhibit 158: Teleflex Inc. - Segment focus
• 12.16 Unetixs Vascular Inc.
• Exhibit 159: Unetixs Vascular Inc. - Overview
• Exhibit 160: Unetixs Vascular Inc. - Product / Service
• Exhibit 161: Unetixs Vascular Inc. - Key news
• Exhibit 162: Unetixs Vascular Inc. - Key offerings
• 12.17 Viasonix Ltd
• Exhibit 163: Viasonix Ltd - Overview
• Exhibit 164: Viasonix Ltd - Product / Service
• Exhibit 165: Viasonix Ltd - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 168: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources
• 13.5 List of abbreviations
• Exhibit 172: List of abbreviations